Biotech Takes Electrifying Approach To Developing An HIV Vaccine
Executive Summary
In the tumultuous quest to create an effective HIV vaccine, an approach that combines a DNA vaccine with a jolt of electricity looks to be a promising candidate in monkeys, but more data is needed in humans before breaking out the champagne, researchers say
You may also be interested in...
HIV Vaccine Work Awaits Next STEP In Merck Analysis; Failure Aids Biomarker
Plans for PAVE 100, the National Institute on Allergy and Infectious Diseases' Phase IIb HIV vaccine study, remain on hold until the next wave of Merck's STEP data - also expected to aid preclinical vaccine development - is released, researchers say
Merck, NIH Cannot Explain Higher Number Of AIDS Cases In HIV Vaccinated Individuals
In some instances, the vaccine may have led to an increase in HIV infections.
Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: